publication venue for
- Influence of induction therapy and antiretroviral regimen on outcomes in kidney transplant recipients living with human immunodeficiency.. 26:-. 2024
- Disseminated Scedosporium infection in the early post-kidney transplant period.. 26:-. 2024
- Cytomegalovirus Immune reconstitution in cord blood transplant recipients on letermovir prophylaxis.. 25:-. 2023
- Biofire pneumonia panel in lung donors: faster detection but limited pathogens.. 25:-. 2023
- Disparities in vaccination rates in solid organ transplant patients.. 25:-. 2023
- Antimicrobial stewardship in solid organ transplant recipients: Current challenges and proposed metrics.. 24:-. 2022
- Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients.. 23:-. 2021
- Rapid molecular detection of airway pathogens in lung transplant recipients.. 23:-. 2021
- Cytomegalovirus myocarditis in solid organ transplant recipients: A case series and review of literature.. 22:-. 2020
- Severe acute Q fever pneumonia complicated by presumed persistent localized Q fever endocarditis in a renal transplant recipient: A case report and review of the literature.. 22:-. 2019
- Toxoplasmosis in non-cardiac solid organ transplant recipients: A case series and review of literature.. 22:-. 2019
- Successful optimization of antiretroviral regimens in treatment-experienced people living with HIV undergoing liver transplantation.. 21:-. 2019
- Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: A single center experience.. 21:-. 2019
- Kidney transplant recipients with polycystic kidney disease have a lower risk of post-transplant BK infection than those with end-stage renal disease due to other causes.. 20:-. 2018
- Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.. 17:14-20. 2015
- Scedosporium prolificans pericarditis and mycotic aortic aneurysm in a lung transplant recipient receiving voriconazole prophylaxis.. 15:E70-4. 2013
- Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.. 14:248-58. 2012